{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:51:41Z","timestamp":1760853101030},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"8-9","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Neural Transmission"],"published-print":{"date-parts":[[1997,8]]},"DOI":"10.1007\/bf01285555","type":"journal-article","created":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T20:11:33Z","timestamp":1111695093000},"page":"875-885","source":"Crossref","is-referenced-by-count":11,"title":["Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic canine substantia nigra cultures"],"prefix":"10.1007","volume":"104","author":[{"given":"D. E.","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. H.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"Lynn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"W. O.","family":"Whetsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01285555_CR1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0014-2999(93)90897-Q","volume":"240","author":"OM Adeyemo","year":"1993","unstructured":"Adeyemo OM, Youdim MBH, Markey SP, Markey CJ, Pollard HB (1993) L-deprenyl confers specific protection against MPTP-induced Parkinson's disease-like movement disorder in the goldfish. Eur J Pharmacol 240: 185\u2013193","journal-title":"Eur J Pharmacol"},{"key":"BF01285555_CR2","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1523\/JNEUROSCI.13-09-04042.1993","volume":"13","author":"KS Ansari","year":"1993","unstructured":"Ansari KS, Yu PH, Kruck TPA, Tatton WG (1993) Rescue of axotomized immature rat facial motoneurons by R(\u2212)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J Neurosci 13: 4042\u20134053","journal-title":"J Neurosci"},{"key":"BF01285555_CR3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000407513","volume":"19","author":"W Birkmayer","year":"1983","unstructured":"Birkmayer W, Knoll J, Riederer P, Youdim MB (1983) (\u2212)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease. Mod Probl Pharmacopsychiat 19: 170\u2013176","journal-title":"Mod Probl Pharmacopsychiat"},{"key":"BF01285555_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01245973","volume":"64","author":"W Birkmayer","year":"1985","unstructured":"Birkmayer W, Knoll J, Riederer P, Youdim MB (1985) Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study. J Neural Transm 64: 113\u2013127","journal-title":"J Neural Transm"},{"key":"BF01285555_CR5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/02713689508999923","volume":"14","author":"YM Buys","year":"1995","unstructured":"Buys YM, Trope GE, Tatton WG (1995) (\u2212)-Deprenyl increase the survival of rat retinal ganglion cells after optic nerve crush. Curr Eye Res 14: 119\u2013126","journal-title":"Curr Eye Res"},{"key":"BF01285555_CR6","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/syn.890110410","volume":"11","author":"CC Chiueh","year":"1992","unstructured":"Chiueh CC, Huang S-J, Murphy OL (1992) Enhanced hydroxyl radical generation by 2-methyl analog of MPTP: suppression by clorgyline and deprenyl. Synapse 11: 346\u2013348","journal-title":"Synapse"},{"key":"BF01285555_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-4886(89)90035-6","volume":"104","author":"BC Christie-Pope","year":"1989","unstructured":"Christie-Pope BC, Burns RS, Whetsell WO (1989) Ultrastructural alterations induced by 1-methyl-4-phenylpyridinium (MPP+) in canine substantia nigra and rat mesencephalon in vitro. Exp Neurol 104: 235\u2013240","journal-title":"Exp Neurol"},{"key":"BF01285555_CR8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0022-510X(94)90235-6","volume":"125","author":"Y Iwasaki","year":"1994","unstructured":"Iwasaki Y, Ikeda K, Shiojima T, Kobayashi T, Tagaya N, Kinoshita M (1994) Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons. J Neurol Sci 125: 11\u201313","journal-title":"J Neurol Sci"},{"key":"BF01285555_CR9","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/0922-4106(94)90048-5","volume":"269","author":"E Koutsilieri","year":"1994","unstructured":"Koutsilieri E, O'Callaghan JFX, Chen T-S, Riederer P, Rausch W-D (1994) Selegiline enhances survival and neurite outgrowth of MPP+-treated dopaminergis neurons. Eur J Pharmacol Mol Pharmacol Sect 269: R3-R4","journal-title":"Eur J Pharmacol Mol Pharmacol Sect"},{"key":"BF01285555_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0014-2999(96)00184-7","volume":"306","author":"E Koutsilieri","year":"1996","unstructured":"Koutsilieri E, Chen T-S, Rausch W-D, Riederer P (1996) Selegiline is immunoprotective in primary brain cultures treated with 1-methyl-4-pyridinium. Eur J Pharmacol 306: 181\u2013186","journal-title":"Eur J Pharmacol"},{"key":"BF01285555_CR11","volume-title":"Deprenyl's effect at slowing progression of Parkinsonism disability: the Parkinson Study Group","author":"PA LeWitt","year":"1991","unstructured":"LeWitt PA (1991) Deprenyl's effect at slowing progression of Parkinsonism disability: the Parkinson Study Group. Department of Neurology, Wayne State University School of Medicine, Detroit, MI"},{"key":"BF01285555_CR12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0404.1991.tb05023.x","volume":"136","author":"VV Myllyla","year":"1991","unstructured":"Myllyla VV, Sotaniemi KA, Vuorinen JA, Heinonen EH (1991) Selegiline as a primary treatment of Parkinson's disease. Acta Neurol Scand [Suppl] 136: 70\u201372","journal-title":"Acta Neurol Scand [Suppl]"},{"key":"BF01285555_CR13","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/j.1471-4159.1985.tb10556.x","volume":"45","author":"C Mytilineou","year":"1985","unstructured":"Mytilineou C, Cohen G (1985) Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-pyridinium ion. J Neurochem 45: 1951\u20131953","journal-title":"J Neurochem"},{"key":"BF01285555_CR14","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","volume":"36","author":"WJ Nicklas","year":"1985","unstructured":"Nicklas WJ, Vyos I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by MPP+, a metabolite of the neurotoxin MPTP. Life Sci 36: 2503\u20132508","journal-title":"Life Sci"},{"key":"BF01285555_CR15","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/jnr.490380109","volume":"38","author":"C Oh","year":"1994","unstructured":"Oh C, Murray B, Bhattacharya N, Holland D, Tatton WG (1994) (\u2212)-Deprenyl alters the survival of adult murine facial motoneurons after axotomy: increases in vulnerable C57BL strain but decreases in motor neurodegeneration mutants. J Neurosci Res 38: 64\u201374","journal-title":"J Neurosci Res"},{"key":"BF01285555_CR16","first-page":"1363","volume":"321","author":"Parkinson Study Group","year":"1989","unstructured":"Parkinson Study Group (1989) Effect of deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med 321: 1363\u20131371","journal-title":"N Engl J Med"},{"key":"BF01285555_CR17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/jnr.490370213","volume":"37","author":"NA Reniuk","year":"1994","unstructured":"Reniuk NA, Henderson JT, Tatton WG, Doder JC (1994) Increased CNTF gene expression in process-bearing astroyctes following injury is augmented by R(+)-deprenyl. J Neurosci Res 37: 278\u2013286","journal-title":"J Neurosci Res"},{"key":"BF01285555_CR18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jnr.490310223","volume":"31","author":"PT Salo","year":"1992","unstructured":"Salo PT, Tatton WG (1992) Deprenyl reduces the death of motoneurons caused by axotomy. J Neurosci Res 31: 394\u2013400","journal-title":"J Neurosci Res"},{"key":"BF01285555_CR19","first-page":"1680","volume":"19","author":"DE Schmidt","year":"1993","unstructured":"Schmidt DE, Lynn JC, Whetsell WO (1993) Attenuation of 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity by deprenyl in organotypic cultures of canine substantia nigra. Neurosci Abstr 19: 1680","journal-title":"Neurosci Abstr"},{"key":"BF01285555_CR20","first-page":"207","volume":"41","author":"I Sziraki","year":"1994","unstructured":"Sziraki I, Kardos M, Patthy M, Patfalusi M, Gaal J, Solti M, Kollar E, Singer J (1994) Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2\u2032-methyl-MPTP. J Neural Transm [Suppl] 41: 207\u2013210","journal-title":"J Neural Transm [Suppl]"},{"key":"BF01285555_CR21","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1126\/science.2502843","volume":"245","author":"JW Tetrud","year":"1989","unstructured":"Tetrud JW, Langston JW (1989) The effect of deprenyl on the natural history of Parkinson's disease. Science 245: 519\u2013522","journal-title":"Science"},{"key":"BF01285555_CR22","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","volume":"61","author":"KF Tipton","year":"1993","unstructured":"Tipton KF, Singer TP (1993) Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds. J Neurochem 61: 1191\u20131206","journal-title":"J Neurochem"},{"key":"BF01285555_CR23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1017\/S0317167100041524","volume":"19","author":"P Vezina","year":"1992","unstructured":"Vezina P, Mohr E, Grimes D (1992) Deprenyl in Parkinson's disease: mechanisms, neuroprotective effect, indications and adverse effects. Can J Neurol Sci 19: 142\u2013146","journal-title":"Can J Neurol Sci"},{"key":"BF01285555_CR24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF01249600","volume":"52","author":"WO Whetsell","year":"1981","unstructured":"Whetsell WO, Mytileneou C, Shen J, Yahr MD (1981) The development of the dog nigrostriatal system in organotypic culture. J Neural Transm 52: 149\u2013161","journal-title":"J Neural Transm"},{"key":"BF01285555_CR25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0014-2999(93)90181-G","volume":"243","author":"R-M Wu","year":"1993","unstructured":"Wu R-M, Chiueh CC, Pert A, Murphy DL (1993) Apparent antioxidant effect of 1-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo. Eur J Pharmacol 243: 241\u2013247","journal-title":"Eur J Pharmacol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01285555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01285555\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01285555","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01285555.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T19:44:11Z","timestamp":1581968651000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01285555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":25,"journal-issue":{"issue":"8-9","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["BF01285555"],"URL":"https:\/\/doi.org\/10.1007\/bf01285555","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,8]]}}}